LGVN · Longeveron Inc
United States · RS rating 89 · As of 2026-11-03
| Price | 1.78 USD |
|---|---|
| 1-day change | +4.1% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 13 / 97 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 29 / 41 / 38 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +0.0% |
| Sales growth Q/Q | +166.4% |
| Distance from 52-week high | +75.7% |
| Market cap (USD) | $28.6M |